Cefuroxime and Arteriospasm coronary - a phase IV clinical study of FDA data

Summary:

Arteriospasm coronary is reported as a side effect among people who take Cefuroxime (cefuroxime sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Clopidogrel, and have Perioperative analgesia.

The phase IV clinical study analyzes which people have Arteriospasm coronary when taking Cefuroxime. It is created by eHealthMe based on reports of 12,808 people who have side effects when taking Cefuroxime from the FDA, and is updated regularly.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.

What is Arteriospasm coronary?

Arteriospasm coronary (spasm of the large- or medium-sized coronary arteries) is found to be associated with 332 drugs and 499 conditions by eHealthMe. Check the latest studies of Arteriospasm coronary.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

12,808 people reported to have side effects when taking Cefuroxime.
Among them, 20 people (0.16%) have Arteriospasm coronary.

Could Cefuroxime cause Arteriospasm coronary?

Among these 20 people:

How long have people been on Cefuroxime when they have Arteriospasm coronary? *

What is the gender of people who have Arteriospasm coronary when taking Cefuroxime? *

female: 70 %
male: 30 %

What is the age of people who have Arteriospasm coronary when taking Cefuroxime? *

What are other drugs people take besides Cefuroxime? *

What are other side effects people have besides Arteriospasm coronary? *

Hypotension (abnormally low blood pressure): 12 people, 60.00%
Kounis Syndrome (the concurrence of heart pain with conditions associated with mast cell activation leads to heart muscle damage): 11 people, 55.00%
Cardiac Arrest: 8 people, 40.00%
Pulseless Electrical Activity: 7 people, 35.00%
Chest Pain: 6 people, 30.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 6 people, 30.00%
Heart Attack: 6 people, 30.00%
Hypersensitivity: 5 people, 25.00%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 5 people, 25.00%
Electrocardiogram St Segment Elevation: 4 people, 20.00%

What are the existing conditions these people have? *

Perioperative Analgesia: 8 people, 40.00%
Hypotonia (low muscle tone): 7 people, 35.00%
General Anaesthesia: 7 people, 35.00%
Hypotension (abnormally low blood pressure): 6 people, 30.00%
Upper Respiratory Tract Infection: 1 person, 5.00%
Local Anaesthesia: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefuroxime and have Arteriospasm coronary?

- Check whether Arteriospasm coronary is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefuroxime:

Cefuroxime (12,999 reports)

Browse all side effects of Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arteriospasm coronary:

Arteriospasm coronary (332 drugs)

Browse all the conditions that are associated with Arteriospasm coronary:

Arteriospasm coronary (499 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime sodium (the active ingredients of Cefuroxime) and Cefuroxime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.